The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - AstraZeneca
Tissue and plasma tumor mutation burden (TMB) as predictive biomarkers in the CO.26 trial of durvalumab + tremelimumab (D+T) versus best supportive care (BSC) in metastatic colorectal cancer (mCRC).
 
Jonathan M. Loree
Consulting or Advisory Role - AMGEN; Bayer; Eisai; Ipsen; Novartis; Pfizer; Taiho Pharmaceutical
Research Funding - Ipsen (Inst)
 
James T. Topham
No Relationships to Disclose
 
Hagen F. Kennecke
Honoraria - Advanced Accelerator Applications; Ipsen
Speakers' Bureau - Advanced Accelerator Applications
Research Funding - Taiho Pharmaceutical (Inst)
 
Harriet Feilotter
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Diaceutics; Janssen Diagnostics; Precision RxDx; Roche Canada
Consulting or Advisory Role - Astellas Pharma; Janssen Diagnostics; LEK; Precision RxDx; Roche Canada
Speakers' Bureau - Bayer
Research Funding - AstraZeneca (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen Diagnostics; Roche Canada; Thermo Fisher Scientific
 
Faeze Keshavarz-Rahaghi
No Relationships to Disclose
 
Young S Lee
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Weimin Li
No Relationships to Disclose
 
Katie Quinn
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Kimberly Banks
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - Guardant Health
 
Daniel John Renouf
Honoraria - Celgene; Ipsen; Roche; SERVIER; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Celgene; SERVIER; Shire; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Bayer (Inst)
 
Derek J. Jonker
No Relationships to Disclose
 
Dongsheng Tu
No Relationships to Disclose
 
Christopher J. O'Callaghan
No Relationships to Disclose
 
Eric Xueyu Chen
Honoraria - Eisai
Research Funding - AstraZeneca/MedImmune; Boston Biomedical; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis